Compare Core Scientific Inc (CORZ) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance

Core Scientific IncTrade

Citius Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Core Scientific Inc vs Citius Pharmaceuticals Inc — how do they compare? Core Scientific Inc trades at $21.44 (market cap $6.35B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Core Scientific Inc is far larger — about 317.3× Citius Pharmaceuticals Inc's market cap, and Core Scientific Inc is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

	CORZ	CTXR
Market Cap	$6.35B	$20.01M
Sector	Technology	Health
52-Week High	$29.16	$1.82
52-Week Low	$13.55	$0.48
Enterprise Value	$8.88B	$16.23M

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CORZ

Neocloud stocks rise as NVIDIA-led $500B AI financing plan boosts data center buildout prospects24/7 Wall Street · 1 day agoBullish CoreWeave Q2 earnings expected in line; Jefferies eyes founder stock sales as next catalyst, profit gains months awayProactive Investors · 1 day agoBullish TeraWulf leads AI infrastructure stocks in 2026 with a 40.82% gain, driven by a major Anthropic lease deal.24/7 Wall Street · 1 day agoBullish View details →

CTXR

Citius Oncology appoints Jonathan Peri as new independent board member to strengthen governance.PRNewsWire · 4 hours agoBullish View details →

About Core Scientific Inc

Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.